We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.94%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$54.2B
AUM Growth
+$30.1B
(+125%)
Cap. Flow
+$28.6B
Cap. Flow
% of AUM
52.81%
Top 10 Holdings %
Top 10 Hldgs %
15.56%
Holding
4,600
New
1,635
Increased
1,281
Reduced
635
Closed
782
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.08B |
| 2 |
Amazon
AMZN
|
+$1B |
| 3 |
Meta Platforms (Facebook)
META
|
+$844M |
| 4 |
Apple
AAPL
|
+$842M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$725M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$192M |
| 2 |
West Pharmaceutical
WST
|
+$107M |
| 3 |
Advanced Micro Devices
AMD
|
+$97.2M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
+$79.3M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$79.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.77% |
| 2 | Healthcare | 17.47% |
| 3 | Financials | 15.58% |
| 4 | Consumer Discretionary | 12.3% |
| 5 | Communication Services | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
NovoCure
NVCR
$1.89B
| $268K | ﹤0.01% |
+3,572
| New | +$359K |
|
3052
Nurix Therapeutics
NRIX
$2.51B
| $267K | ﹤0.01% |
+9,202
| New | +$279K |
|
3053
MKS Inc
MKSI
$19.3B
| $266K | ﹤0.01% |
1,529
-89,830
| -98% | -$14M |
|
3054
National Bank Holdings
NBHC
$1.9B
| $266K | ﹤0.01% |
6,052
-7,225
| -54% | -$315K |
|
3055
Information Services Group
III
$199M
| $265K | ﹤0.01% |
34,822
-543,285
| -94% | -$4.37M |
|
3056
Nkarta
NKTX
$159M
| $264K | ﹤0.01% |
+17,253
| New | +$296K |
|
|
TBCH
3057
Turtle Beach Corp
TBCH
$258M
| $263K | ﹤0.01% |
+11,752
| New | +$317K |
|
3058
Assurant
AIZ
$14B
| $260K | ﹤0.01% |
+1,668
| New | +$265K |
|
|
SMLR
3059
DELISTED
Semler Scientific
SMLR
| $260K | ﹤0.01% |
+2,837
| New | +$318K |
|
3060
iShares US Healthcare Providers ETF
IHF
$1.24B
| $259K | ﹤0.01% |
+4,475
| New | +$244K |
|
|
RFP
3061
DELISTED
Resolute Forest Products Inc.
RFP
| $259K | ﹤0.01% |
16,922
+1,876
| +12% | +$23.7K |
|
3062
Independence Realty Trust
IRT
$3.93B
| $258K | ﹤0.01% |
+9,917
| New | +$235K |
|
|
DAO
3063
Youdao
DAO
$1.93B
| $257K | ﹤0.01% |
20,758
-179,587
| -90% | -$2.33M |
|
|
AMBR
3064
Amber International Holding Ltd
AMBR
$132M
| $257K | ﹤0.01% |
+5,558
| New | +$342K |
|
3065
Alarm.com
ALRM
$2.7B
| $256K | ﹤0.01% |
3,008
-566
| -16% | -$46.3K |
|
3066
Superior Group of Companies
SGC
$202M
| $256K | ﹤0.01% |
+11,671
| New | +$278K |
|
|
DISH
3067
DELISTED
DISH Network Corp.
DISH
| $256K | ﹤0.01% |
7,910
-168
| -2% | -$6.26K |
|
3068
Gulfport Energy Corp
GPOR
$2.76B
| $254K | ﹤0.01% |
3,530
-1,840
| -34% | -$143K |
|
3069
Syndax Pharmaceuticals
SNDX
$1.74B
| $254K | ﹤0.01% |
11,637
| – | – |
|
3070
Asana
ASAN
$1.89B
| $253K | ﹤0.01% |
+3,399
| New | +$360K |
|
3071
Citizens & Northern Corp
CZNC
$450M
| $252K | ﹤0.01% |
9,650
-7,850
| -45% | -$204K |
|
3072
PUT
State Street SPDR S&P Bank ETF
KBE
$1.66B
| $250K | ﹤0.01% |
4,600
| – | – |
|
3073
CPI Card Group
PMTS
$243M
| $250K | ﹤0.01% |
13,501
+4,667
| +53% | +$111K |
|
|
TRIT
3074
DELISTED
Triterras, Inc. Class A Ordinary Shares
TRIT
| $250K | ﹤0.01% |
+106,594
| New | +$530K |
|
|
INZY
3075
DELISTED
Inozyme Pharma
INZY
| $247K | ﹤0.01% |
36,033
+2,625
| +8% | +$22.7K |
|
Similar funds
Marshall Wace's Q4 2021 Portfolio in Review
As of Q4 2021, Marshall Wace held 4,600 positions worth $54.2B, up 125% from $24.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $28.6B of net new capital in Q4 2021, opening 1,635 new positions and adding to 1,281 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Accenture, an estimated $192M trimmed.
- Marshall Wace's largest Q4 2021 buy was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
- Marshall Wace added most to Microsoft in Q4 2021, an estimated $1.08B increase.
- Marshall Wace's biggest Q4 2021 reduction was Accenture, cutting an estimated $192M.
- Marshall Wace fully exited Sabre in Q4 2021, selling an estimated $44.1M.
- Marshall Wace's ten largest holdings make up 16% of its $54.2B portfolio in Q4 2021.
- Marshall Wace opened 1,635 new positions and closed 782 in Q4 2021.
- Marshall Wace's portfolio value rose 125% quarter-over-quarter to $54.2B.
Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.